This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

MWV Healthcare To Present At Inaugural Pharmapack North America Conference

MeadWestvaco Corporation (NYSE: MWV), a global leader in packaging and packaging solutions, will present at Pharmapack North America’s inaugural conference at the Pennsylvania Convention Center in Philadelphia, May 22 – 23, 2012.

The first presentation, entitled "The Demonstrated Impact of Packaging on Patient Adherence," will be led by John Grinnell, vice president and managing director, of MWV Healthcare's Secondary & Adherence Packaging Division, as part of the “Exploring the Human Interaction with Pharmaceutical Packaging” session to be held Tuesday, May 22 from 9:15am-10:40am.

Grinnell will review MWV research demonstrating packaging’s role as a scalable and cost-effective solution to improve poor medication adherence, a significant public health threat recognized by the Health and Human Services (HHS) Office of the Surgeon General. MWV’s unprecedented peer-reviewed study, A Pharmacoepidemiologic Analysis of the Impact of Calendar Blister Packaging on Adherence to Self-Administered Medications for Long-Term Use, evaluates the impact on adherence of using reminder packaging compared to traditional pill vials in a real world setting.

The second presentation, “Equivalence in Nasal Pump Systems for Generic Products in the US Market,” will be led by Rabih Karam, North American sales manager, MWV Healthcare, as part of the “Emerging Technologies in Drug Delivery” session to be held Wednesday, May 23 from 10:50am-12:40pm.

Karam will discuss how bioequivalence studies are an essential part of registration dossiers for the formulation and manufacture of generic medicines; the rigorous standards for performing bioequivalency studies; and how equivalence criteria extends to the drug delivery components used in generic medicines. As part of the discussion, Karam will reference the process and capabilities required to generate equivalence data for MWV nasal devices.

The media are invited to the conference, and Grinnell and Karam are available for interviews.

Please click on the names below for more information on the speakers:

For more information on MWV’s healthcare packaging solutions, please visit: http://www.meadwestvaco.com/HealthcarePackagingSolutions/index.htm

About MWV

MeadWestvaco Corporation (NYSE: MWV), provides packaging solutions to many of the world’s most-admired brands in the healthcare, beauty and personal care, food, beverage, home and garden, and tobacco industries. The company's businesses also include Specialty Chemicals, and the Community Development and Land Management Group, which sustainably manages the company’s land holdings to support its operations, and to provide for conservation, recreation and development opportunities. With 15,000 employees worldwide, MWV operates in 30 countries and serves customers in more than 100 nations. MWV manages all of its forestlands in accordance with internationally recognized forest certification standards, and has been named to the Dow Jones Sustainability World Index for eight consecutive years. For more information, please visit www.mwv.com.



Stock quotes in this article: MWV 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 +2.54 0.14%
NASDAQ 4,095.5160 +9.2910 0.23%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs